Literature DB >> 25172800

HCV E2 core structures and mAbs: something is still missing.

Matteo Castelli1, Nicola Clementi1, Giuseppe A Sautto1, Jennifer Pfaff2, Kristen M Kahle2, Trevor Barnes2, Benjamin J Doranz2, Matteo Dal Peraro3, Massimo Clementi1, Roberto Burioni1, Nicasio Mancini4.   

Abstract

The lack of structural information on hepatitis C virus (HCV) surface proteins has so far hampered the development of effective vaccines. Recently, two crystallographic structures have described the core portion (E2c) of E2 surface glycoprotein, the primary mediator of HCV entry. Despite the importance of these studies, the E2 overall structure is still unknown and, most importantly, several biochemical and functional studies are in disagreement with E2c structures. Here, the main literature will be discussed and an alternative disulfide bridge pattern will be proposed, based on unpublished human monoclonal antibody reactivity. A modeling strategy aiming at recapitulating the available structural and functional studies of E2 will also be proposed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172800      PMCID: PMC4706463          DOI: 10.1016/j.drudis.2014.08.011

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  62 in total

1.  Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.

Authors:  Kathleen McCaffrey; Irene Boo; Kevin Tewierek; Mark L Edmunds; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Version 1.2 of the Crystallography and NMR system.

Authors:  Axel T Brunger
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.

Authors:  Heidi E Drummer; Irene Boo; Anne L Maerz; Pantelis Poumbourios
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 4.  Hepatitis C treatment: an incipient therapeutic revolution.

Authors:  Andrew S deLemos; Raymond T Chung
Journal:  Trends Mol Med       Date:  2014-03-11       Impact factor: 11.951

5.  Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

Authors:  M Flint; C Maidens; L D Loomis-Price; C Shotton; J Dubuisson; P Monk; A Higginbottom; S Levy; J A McKeating
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.

Authors:  Dimitri Lavillette; Eve-Isabelle Pécheur; Peggy Donot; Judith Fresquet; Jennifer Molle; Romuald Corbau; Marlène Dreux; François Penin; François-Loïc Cosset
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

Review 7.  How hepatitis C virus invades hepatocytes: the mystery of viral entry.

Authors:  Yong-Zhe Zhu; Xi-Jing Qian; Ping Zhao; Zhong-Tian Qi
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

8.  Three-dimensional structures of membrane proteins from genomic sequencing.

Authors:  Thomas A Hopf; Lucy J Colwell; Robert Sheridan; Burkhard Rost; Chris Sander; Debora S Marks
Journal:  Cell       Date:  2012-05-10       Impact factor: 41.582

Review 9.  Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies.

Authors:  Giuseppe Sautto; Alexander W Tarr; Nicasio Mancini; Massimo Clementi
Journal:  Clin Dev Immunol       Date:  2013-07-09

10.  Fast and accurate multivariate Gaussian modeling of protein families: predicting residue contacts and protein-interaction partners.

Authors:  Carlo Baldassi; Marco Zamparo; Christoph Feinauer; Andrea Procaccini; Riccardo Zecchina; Martin Weigt; Andrea Pagnani
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more
  13 in total

1.  Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Authors:  Edgar Davidson; Christopher Bryan; Rachel H Fong; Trevor Barnes; Jennifer M Pfaff; Manu Mabila; Joseph B Rucker; Benjamin J Doranz
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

3.  HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.

Authors:  Andrew I Flyak; Stormy Ruiz; Michelle D Colbert; Tiffany Luong; James E Crowe; Justin R Bailey; Pamela J Bjorkman
Journal:  Cell Host Microbe       Date:  2018-11-14       Impact factor: 21.023

4.  Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.

Authors:  Jennifer M Pfaff-Kilgore; Edgar Davidson; Kathryn Kadash-Edmondson; Mayda Hernandez; Erin Rosenberg; Ross Chambers; Matteo Castelli; Nicola Clementi; Nicasio Mancini; Justin R Bailey; James E Crowe; Mansun Law; Benjamin J Doranz
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

Review 5.  Viral evasion and challenges of hepatitis C virus vaccine development.

Authors:  Brian G Pierce; Zhen-Yong Keck; Steven Kh Foung
Journal:  Curr Opin Virol       Date:  2016-09-19       Impact factor: 7.090

6.  Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

Authors:  Giuseppe A Sautto; Karin Wisskirchen; Nicola Clementi; Matteo Castelli; Roberta A Diotti; Julia Graf; Massimo Clementi; Roberto Burioni; Ulrike Protzer; Nicasio Mancini
Journal:  Gut       Date:  2015-02-06       Impact factor: 23.059

7.  A Biologically-validated HCV E1E2 Heterodimer Structural Model.

Authors:  Matteo Castelli; Nicola Clementi; Jennifer Pfaff; Giuseppe A Sautto; Roberta A Diotti; Roberto Burioni; Benjamin J Doranz; Matteo Dal Peraro; Massimo Clementi; Nicasio Mancini
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

Review 8.  Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus.

Authors:  Thomas R Fuerst; Brian G Pierce; Zhen-Yong Keck; Steven K H Foung
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

9.  The unexpected structures of hepatitis C virus envelope proteins.

Authors:  Yunyun Wang; Jing Wang; Shanshan Wu; Haihong Zhu
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

Review 10.  Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2.

Authors:  Luisa J Ströh; Kumar Nagarathinam; Thomas Krey
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.